Enrichment of minor allele of SNPs and genetic prediction of type 2 diabetes risk in British population

PloS One
Xiaoyun Lei, Shi Huang

Abstract

Type 2 diabetes (T2D) is a complex disorder characterized by high blood sugar, insulin resistance, and relative lack of insulin. The collective effects of genome wide minor alleles of common SNPs, or the minor allele content (MAC) in an individual, have been linked with quantitative variations of complex traits and diseases. Here we studied MAC in T2D using previously published SNP datasets and found higher MAC in cases relative to matched controls. A set of 357 SNPs was found to have the best predictive accuracy in a British population. A weighted risk score calculated by using this set produced an area under the curve (AUC) score of 0.86, which is comparable to risk models built by phenotypic markers. These results identify a novel genetic risk element in T2D susceptibility and provide a potentially useful genetic method to identify individuals with high risk of T2D.

References

May 15, 1997·Statistics in Medicine·D W HosmerS Lemeshow
Mar 12, 1998·Nature·D J WithersM F White
Oct 7, 2004·The Journal of Clinical Investigation·Matthew J Brady
Apr 9, 2005·European Journal of Endocrinology·D Kapoor, T H Jones
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Carole WilliJacques Cornuz
Jan 15, 2008·Lancet·UNKNOWN Cholesterol Treatment Trialists' (CTT) CollaboratorsC Baigent
Feb 22, 2008·Nature·Kate E JonesPeter Daszak
Nov 21, 2008·The New England Journal of Medicine·James B MeigsL Adrienne Cupples
Jan 10, 2009·Nature Protocols·Da Wei HuangRichard A Lempicki
May 2, 2009·Science·Sarah A TishkoffScott M Williams
Jul 3, 2009·Nature·UNKNOWN International Schizophrenia ConsortiumPamela Sklar
Jun 29, 2010·Nature Genetics·Benjamin F VoightUNKNOWN GIANT Consortium
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Dec 21, 2010·American Journal of Human Genetics·Jian YangPeter M Visscher
Mar 24, 2011·Human Molecular Genetics·Jia KangUNKNOWN NIDDK IBD Genetics Consortium
Aug 30, 2011·Human Molecular Genetics·Luke Jostins, Jeffrey C Barrett
Apr 14, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Jason L Vassy, James B Meigs
Sep 8, 2012·Nature·UNKNOWN ENCODE Project Consortium
Aug 2, 2013·Diabetes Care·Valeriya Lyssenko, Markku Laakso
Aug 21, 2013·World Journal of Diabetes·Omar Ali
Dec 6, 2014·Diabetes·Philippa J TalmudUNKNOWN UCLEB Consortium
Jan 1, 2015·Bioinformatics·Jack EuesdenPaul F O'Reilly
Jan 9, 2015·Medicine·Nita Gandhi Forouhi, Nicholas J Wareham
Jul 12, 2016·Nature·Christian FuchsbergerMark I McCarthy
Feb 15, 2017·PLoS Genetics·Saskia P HagenaarsRiccardo E Marioni
Jun 18, 2017·Cell·Evan A BoyleJonathan K Pritchard
Sep 17, 2017·Scientific Reports·Pei HeShi Huang

❮ Previous
Next ❯

Methods Mentioned

BETA
chip
genotyping
PCA
blood draw

Software Mentioned

pROC
PLINK
Prism
ANNOVAR
WTCCC
GCTA
R
fmsb R
DAVID
PRSice

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.